These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15951302)

  • 21. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
    Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
    Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
    Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
    Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
    Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
    Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
    Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
    Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
    Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
    Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
    Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
    Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
    Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
    Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
    Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
    Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
    Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
    Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
    Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
    Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
    Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
    Gautschi O; Ratschiller D; Gugger M; Betticher DC; Heighway J
    Lung Cancer; 2007 Jan; 55(1):1-14. PubMed ID: 17070615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
    Masamha CP; Albrecht TR; Wagner EJ
    J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
    Balcerczak E; Pasz-Walczak G; Kumor P; Panczyk M; Kordek R; Wierzbicki R; Mirowski M
    Eur J Surg Oncol; 2005 Sep; 31(7):721-6. PubMed ID: 15993030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
    Wickham CL; Armitage H; Joyner MV; Sarsfield P; Boyce M; Wilkins BS; Jones DB; Ellard S
    Med Oncol; 2003; 20(1):77-85. PubMed ID: 12665688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
    Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
    Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.